Spectral ai announces total u.s. and international patent portfolio now stands at 26 granted patents and 38 pending applications in support of its ai-driven deepview system

Dallas, july 24, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a 30% increase in its patent portfolio that strengthens and protects its proprietary, ai-driven deepview system wound assessment platform.
MDAI Ratings Summary
MDAI Quant Ranking